tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

NBIX Stock Latest News

Neurocrine price target raised to $182 from $172 at BofA
The FlyNeurocrine price target raised to $182 from $172 at BofA
9h ago
NBIX
Neurocrine says Crenessity now available in U.S.
PremiumThe Fly
Neurocrine says Crenessity now available in U.S.
13h ago
NBIX
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
1d ago
AVXL
CRVS
Top 3 Trending Stocks, According to Analysts – 12/18/2024  
PremiumMarket News
Top 3 Trending Stocks, According to Analysts – 12/18/2024  
3d ago
NKE
NBIX
Neurocrine announces FDA approval of crenessity
PremiumThe Fly
Neurocrine announces FDA approval of crenessity
7d ago
NBIX
Evercore says failure of emraclidine ‘may’ be ‘substantial’ Neurocrine positive
PremiumThe FlyEvercore says failure of emraclidine ‘may’ be ‘substantial’ Neurocrine positive
1M ago
BMY
ABBV
Neurocrine’s Ingrezza shows efficacy in Huntington’s Disease Chorea
Premium
The Fly
Neurocrine’s Ingrezza shows efficacy in Huntington’s Disease Chorea
1M ago
NBIX
Neurocrine presents data from Ingrezza studies on tardive dyskines patients
Premium
The Fly
Neurocrine presents data from Ingrezza studies on tardive dyskines patients
2M ago
NBIX
Neurocrine presents data from long-term KINECT-4 study
PremiumThe Fly
Neurocrine presents data from long-term KINECT-4 study
2M ago
NBIX
Neurocrine Biosciences’ $300M Share Buyback Plan: Potential Risks and Market Volatility Concerns
PremiumCompany Announcements
Neurocrine Biosciences’ $300M Share Buyback Plan: Potential Risks and Market Volatility Concerns
2M ago
NBIX
Neurocrine Biosciences Reports Strong Q3 2024 Earnings
PremiumCompany Announcements
Neurocrine Biosciences Reports Strong Q3 2024 Earnings
2M ago
NBIX
Neurocrine reports Q3 non-GAAP EPS $1.81, consensus $1.50
PremiumThe Fly
Neurocrine reports Q3 non-GAAP EPS $1.81, consensus $1.50
2M ago
NBIX
Neurocrine sees FY24 Ingrezza revenue $2.300B-$2.320B
PremiumThe FlyNeurocrine sees FY24 Ingrezza revenue $2.300B-$2.320B
2M ago
NBIX
Neurocrine participates in a conference call with Needham
Premium
The Fly
Neurocrine participates in a conference call with Needham
2M ago
NBIX
NBIX Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
NBIX Earnings this Week: How Will it Perform?
2M ago
NBIX
AbbVie price target raised to $195 from $185 at BofA
PremiumThe Fly
AbbVie price target raised to $195 from $185 at BofA
2M ago
BMY
ABBV
Neurocrine price target lowered to $114 from $128 at BMO Capital
PremiumThe Fly
Neurocrine price target lowered to $114 from $128 at BMO Capital
2M ago
NBIX
Neurocrine Biosciences Names Dr. Gano as President and CEO
PremiumCompany Announcements
Neurocrine Biosciences Names Dr. Gano as President and CEO
2M ago
8K
NBIX
Nike upgraded, PayPal downgraded: Wall Street’s top analyst calls
PremiumThe Fly
Nike upgraded, PayPal downgraded: Wall Street’s top analyst calls
2M ago
CVS
EAT
Neurocrine resumed with an Outperform at Raymond James
PremiumThe FlyNeurocrine resumed with an Outperform at Raymond James
2M ago
NBIX
Neurocrine announces interim results from ongoing KINECT-HD2 study
Premium
The Fly
Neurocrine announces interim results from ongoing KINECT-HD2 study
3M ago
NBIX
Voyager advances Neurocrine collaboration, selects third gene therapy candidate
Premium
The Fly
Voyager advances Neurocrine collaboration, selects third gene therapy candidate
3M ago
NBIX
VYGR

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >